Peer-influenced content. Sources you trust. No registration required. This is HCN.
MedTech Dive
As the market for wearable healthcare devices evolves at a significant pace, physicians will find valuable insights into shifts in usage patterns, demographics, and device popularity in this recent survey.
All Specialties July 6th 2023
Optometry and Vision Science (OVS)
The intricate relationship between US youth and eyeglass usage is ridden with barriers such as cost, aesthetics, discomfort, and inconvenience. To combat the widespread issue of uncorrected refractive errors, a multi-faceted approach is essential.
Optometry June 26th 2023
British Medical Journal
It’s clear that addressing the carbon footprint in intensive care units (ICUs) is an important area of concern in tackling the climate crisis. As ICUs are a carbon hotspot, various measures can be taken to reduce their impact on the environment without compromising patient care.
Cardiology June 14th 2023
Annals of Internal Medicine
Similarities in Quality and Cost of Care: Allopathic vs. Osteopathic Physicians As the medical field continues to evolve and diversify, it is imperative to understand the impact of physician education on patient outcomes and healthcare costs. This comprehensive observational study offers an insightful comparison between allopathic and osteopathic physicians in the context of hospitalized Medicare patients, revealing striking similarities in both the quality and cost of care provided.
Family Medicine/General Practice June 6th 2023
Journal of Pharmaceutical Policy and Practice
Unraveling Patient Perspectives on DOAC Safety: Key Findings and Implications for Healthcare Practice A recent study that delves into the complex interactions of direct oral anticoagulants (DOACs) usage offers insightful information about patient experiences and suggests ways to increase patients’ safety and adherence.
Cardiology June 6th 2023
Cancer Therapy Advisor
Oncologists transitioning to industry roles—a significant trend seen in recent years that may have profound implications for patient care. A recent JCO Oncology Practice study reveals a surprising shift in the field of oncology. It suggests that a significant 20% of US oncologists transitioned away from patient-facing roles between 2015 and 2022. To ascertain this, researchers tapped into the Centers for Medicare & Medicaid Services’ national provider database. This database helped identify oncologists who ceased billing during the specified period, marking their shift away from direct patient care. From the 16,870 oncologists examined, 21% had moved away from patient-facing roles by 2022. Interestingly, these included oncologists specializing in hematology/oncology, radiation oncology, medical oncology, gynecologic oncology, and surgical oncology. Attrition rates differed based on experience level, with oncologists having over 30 years of experience showing a notably higher attrition rate (45%) than those with less than 30 years (11%). Diving further, the researchers conducted a subanalysis on oncologists who left patient-facing roles. Their data reveals that 26% of these oncologists transitioned to pharmaceutical and biotechnology roles. Additionally, this move towards industry roles correlated with previous receipt of industry funding, pointing towards a possible link between industry funding and career shifts. This […]
Hematology May 30th 2023